XML 46 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1Close
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 401 $ 236
Short-term investments 8 3
Accounts receivable, net 1,279 1,411
Inventories 1,450 1,597
Prepaid expenses and assets held for sale 261 62
Total current assets 3,399 3,309
Property, plant and equipment, net 2,370 2,407
Intangible assets, net 1,303 1,301
Other assets 570 544
Total assets 7,642 7,561 Close
Current liabilities:    
Short-term borrowings 448 543
Accounts payable 778 873
Accrued liabilities and liabilities held for sale 546 466
Total current liabilities 1,772 1,882
Long-term debt 1,740 1,940
Other non-current liabilities 480 477
Total liabilities 3,992 4,299 Close
Share-based payments subject to redemption 55 48
Redeemable non-controlling interests 43 51 Close
Ingredion stockholders’ equity:    
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200.0 shares — $0.01 par value, 77.8 issued at December 31, 2023 and 2022 1 1
Additional paid-in capital 1,146 1,132
Less: Treasury stock (common stock: 12.6 and 12.1 shares at December 31, 2023 and 2022, respectively) at cost (1,207) (1,148)
Accumulated other comprehensive loss (1,056) (1,048)
Retained earnings 4,654 4,210
Total Ingredion stockholders’ equity 3,538 3,147
Non-redeemable non-controlling interests 14 16
Total stockholders' equity 3,552 3,163 Close
Total liabilities and stockholders' equity $ 7,642 $ 7,561